TITLE

Response to Scalori et al

AUTHOR(S)
Lebovics, Edward; Dworkin, Brad M.; Rosenthal, William S.
PUB. DATE
October 1996
SOURCE
American Journal of Gastroenterology;Oct1996, Vol. 91 Issue 10, p2250
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
Presents a response to a letter to the editor regarding the term breakthrough used in a study on chronic hepatitis C patients treated with recombinant interferon.
ACCESSION #
16106950

 

Related Articles

  • Pegylated Interferon-α2b and Lamivudine in Hepatitis B e Antigen-Positive Chronic Hepatitis B. ter Borg, Martijn J.; Janssen, Harry L. A. // Annals of Internal Medicine;9/6/2005, Vol. 143 Issue 5, p391 

    Presents a letter to the editor on pegylated interferon in patients with hepatitis B e antigen.

  • Treatment of Acute Hepatitis C with Interferon Alfa-2b. Tocci, Guido; Visco-Comandini, Ubaldo; Antonucci, Giorgio // New England Journal of Medicine;4/4/2002, Vol. 346 Issue 14, p1091 

    A letter to the editor is presented in response to a study on the treatment of acute hepatitis C virus (HCV) infection with interferon alfa-2b by researcher Elmar Jaeckel and colleagues in the November 15, 2001 issue.

  • Nephrectomy for Metastatic Renal-Cell Cancer. Copur, M. Sitki; Ledakis, Peter; Norvell, Max // New England Journal of Medicine;4/4/2002, Vol. 346 Issue 14, p1095 

    A letter to the editor is presented in response to a study on nephrectomy prolonging survival in metastatic renal-cell cancer patients, who are treated with interferon alfa-2b by researcher Robert C. Flanigan and colleagues in the December 6, 2001 issue.

  • Interferon Gamma-1b for Pulmonary Fibrosis. Hill, A. Ross // New England Journal of Medicine;4/22/2004, Vol. 350 Issue 17, p1794 

    A letter to the editor is presented in response to the article "A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis," by G. Raghu et al. which appeared in the January 8, 2004 issue.

  • Interferon Gamma-1b for Pulmonary Fibrosis. Fruchter, Oren // New England Journal of Medicine;4/22/2004, Vol. 350 Issue 17, p1794 

    A letter to the editor is presented in response to the article "A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis," by G. Raghu et al. which appeared in the January 8, 2004 issue.

  • Interferon Gamma-1b for Pulmonary Fibrosis. Eisner, Mark D. // New England Journal of Medicine;4/22/2004, Vol. 350 Issue 17, p1794 

    A letter to the editor is presented in response to the article "A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis," by G. Raghu et al. which appeared in the January 8, 2004 issue.

  • Interferon Gamma-1b for Pulmonary Fibrosis. Tsoutsou, Pelagia G.; Gourgoulianis, Konstantinos I. // New England Journal of Medicine;4/22/2004, Vol. 350 Issue 17, p1794 

    A letter to the editor is presented in response to the article "A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis," by G. Raghu et al. which appeared in the January 8, 2004 issue.

  • Interferon Gamma-1b for Pulmonary Fibrosis. Vourlekis, Jason S. // New England Journal of Medicine;4/22/2004, Vol. 350 Issue 17, p1794 

    A letter to the editor is presented in response to the article "A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis," by G. Raghu et al. which appeared in the January 8, 2004 issue.

  • Interferon Gamma-1b for Pulmonary Fibrosis. Richeldi, Luca // New England Journal of Medicine;4/22/2004, Vol. 350 Issue 17, p1794 

    A letter to the editor is presented in response to the article "A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis," by G. Raghu et al. which appeared in the January 8, 2004 issue.

  • Interferon Gamma-1b for Pulmonary Fibrosis. Raghu, Ganesh; King, Talmadge E. // New England Journal of Medicine;4/22/2004, Vol. 350 Issue 17, p1794 

    A response by G. Raghu et al. to a letter to the editor about their article "A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis," in the January 1, 2004 issue is presented.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics